Journal List > Korean J Anesthesiol > v.71(4) > 1156571

TOOLS
Lee and Loepke: Does pediatric anesthesia cause brain damage? – Addressing parental and provider concerns in light of compelling animal studies and seemingly ambivalent human data
Review Article

Korean J Anesthesiol 2018;71(4):255-273.

Published online: 4 July 2018

DOI: https://doi.org/10.4097/kja.d.18.00165

Does pediatric anesthesia cause brain damage? – Addressing parental and provider concerns in light of compelling animal studies and seemingly ambivalent human data

Jeong-Rim Lee1, Andreas W. Loepke2

1Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea

2Department of Anesthesiology and Critical Care Medicine, Children’s Hospital of Philadelphia, and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA

Corresponding author: Andreas W. Loepke, M.D., Ph.D. Division of Cardiac Anesthesiology, Department of Anesthesiology and Critical Care Medicine, Children’s Hospital of Philadelphia, Philadelphia, PA 19104, USA Tel: 1-800-879-2467, Fax: 1-2155905824, Email: pedsanesthesia@gmail.com

Received 19 June 2018       Accepted 4 July 2018

Copyright © The Korean Society of Anesthesiologists, 2018

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Anesthesia facilitates surgery in millions of young children every year. Structural brain abnormalities and functional impairment observed in animals have created substantial concerns among clinicians, parents, and government regulators. Clinical studies seemed ambivalent; it remains unclear whether differential species effects exist towards anesthetic exposure. The current literature search and analysis attempts to unify the available clinical and animal studies, which currently comprise of > 530 in vivo animal studies and > 30 clinical studies. The prevalence of abnormalities was lowest for exposures < 1 hour, in both animals and humans, while studies with injurious findings increased in frequency with exposure time. Importantly, no exposure time, anesthetic technique, or age during exposure was clearly identifiable to be entirely devoid of any adverse outcomes. Moreover, the age dependence of maximum injury clearly identified in animal studies, combined with the heterogeneity in age in most human studies, may impede the discovery of a specific human neurological phenotype. In summary, animal and human research studies identify a growing prevalence of injurious findings with increasing exposure times. However, the existing lack of definitive data regarding safe exposure durations, unaffected ages, and non-injurious anesthetic techniques precludes any evidence-based recommendations for drastically changing current clinical anesthesia management. Animal studies focusing on brain maturational states more applicable to clinical practice, as well as clinical studies focusing on prolonged exposures during distinct developmental windows of vulnerability, are urgently needed to improve the safety of perioperative care for thousands of young children requiring life-saving and quality of life-improving procedures daily.

Keywords: Anesthesia, Animal experimentation, Apoptosis, Brain injuries, Cognitive dysfunction, Infant, Neonate, Primates, Rodents

Introduction

General anesthesia allows surgical procedures and stressful interventions to be performed in millions of young children every year. However, developing evidence, predominantly from animal studies, demonstrating structural brain abnormalities and functional impairment following anesthetic exposure, has created substantial concerns among clinicians, parents, and government regulators regarding the safety of this practice. The possibility of long-term adverse effects caused by anesthetic exposures in young children arguably has represented one of the most alarming controversies in anesthesiology [1–5]. As a result, the United States Food and Drug Administration has published a warning regarding repeated or prolonged anesthetic exposures exceeding 3 h in children younger than 3 years of age [6]. To provide guidance for surgical timing, anesthesiologists are therefore increasingly faced with important questions, such as whether there exists a safe exposure time or anesthetic technique and if exposures at certain ages are less injurious than at others. Furthermore, parents, increasingly aware of these concerns, more commonly request information regarding the safety of using anesthetic drugs in their young children. While results from animal studies have been alarming, emerging human studies have been seemingly more equivocal; while some have demonstrated behavioral, learning, and cognitive abnormalities following anesthetic exposures early in life, others, including a recent prospective randomized-controlled trial, have not been able to identify any specific abnormalities or neurological phenotype. Even though a biological explanation is lacking, this might seem to suggest that differential effects exist towards anesthetic exposure’s effects on brain development between humans and other species. Accordingly, the present review analyzes the available animal and human literature, evaluates the body of evidence regarding their translational significance, and provides the anesthesiologist with the most current information for their discussions with parents and other clinicians regarding the potential long-term effects of anesthetic exposure in young children.

Materials and Methods

To identify animal and human studies on the effects of anesthetic exposure on the developing brain, a literature search was performed in April 2018, followed by a systematic analysis of resultant studies, as previously described [7]. Briefly, the search terms ([anesthesia or anesthetic or isoflurane or sevoflurane or desflurane or halothane or enflurane or ketamine or barbiturate or pentobarbital or benzodiazepine or midazolam or diazepam or lorazepam or propofol or dexmedetomidine or xenon] and [toxicity or cell death or apoptosis] and [neuron or brain or spinal cord]), were used for PubMed and Scopus searches, spanning the entire years from 1974 until 2017. English language articles and their references were screened for relevance and articles using animals older than 1 month of age were excluded to focus on the developing brain. Moreover, for subsequent analyses, only in vivo studies were considered to maintain clinical relevance. Eligible studies were inspected for reports of brain structural and/or functional abnormalities and were independently scored by both authors as positive if at least one abnormality, even transiently, was reported. Studies were scored as negative if all analyzed brain structural and/or functional outcomes were reported as indistinguishable from control subjects. For studies designed with separate arms to investigate multiple anesthetics, exposure times, or ages, outcomes for each arm were scored independently. Using this dichotomous approach resulted in 100% agreement amongst the authors’ assessments. To enumerate exposure times, the reported anesthetic durations were quantified as follows: for volatile agents, exposure times were either defined as the reported time of unconsciousness or as spanning from start to discontinuation of the anesthetic. For injectable drugs, exposure duration was established as either the reported duration of unconsciousness, or, for repeated anesthetic injections, the duration was defined as the cumulative multiple of the respective inter-injection intervals. Any studies using single injectable anesthetic exposures that lacked any reported durations of sedative effects and studies specifically reporting that sedation did not reach the level of anesthesia were excluded from subsequent exposure time analysis. To examine the effect of age on subsequent outcomes, the animals’ reported age during exposure for each study was converted to the corresponding maturational stage of the human brain by using a previously described computational neurodevelopmental model [8–10]. The respective species’ process of neurogenesis for the whole brain was translated to the human brain (www.translatingtime.net, accessed 4/10/2018). If repeated exposures were performed at different ages, the median age of exposure was utilized. Outcomes were then dichotomized into negative or positive, as described above.

Results

Most studies on the effects of anesthetic exposure on the developing brain have been performed in animals. Using the described search strategy identified a total of n = 532 relevant laboratory studies on the effects of anesthetics on the developing brain, published between 1974 and 2017 (Fig. 1). The number of publications has risen dramatically over the past two decades, with interest in the topic expressed in review articles, editorials, opinion papers, and letters growing even more rapidly over the years (Fig. 1). Research has been performed in a wide variety of species, including chicks, mice, rats, guinea pigs, swine, sheep, and rhesus monkeys, with many studies describing brain structural and functional abnormalities following exposure to all commonly utilized general anesthetics. The most frequently studied general anesthetic was isoflurane (32% of studies), followed by sevoflurane (25%), ketamine (21%), propofol (14%), desflurane (3%), nitrous oxide, midazolam, halothane, diazepam, enflurane, xenon, lorazepam, chloral hydrate, pentobarbital, thiopental, and phencyclidine. While historically concerns about neurological outcomes were raised for critically ill neonates requiring surgical procedures very early in life, more recently, mostly epidemiological studies on long-term neurological outcomes in healthier patient populations has been increased (Table 1).
Fig. 2 delineates laboratory and clinical studies demonstrating structural and/or functional abnormalities (positive studies) or not finding any abnormalities (negative studies), relative to cumulative exposure times, which ranged from 10 minutes to 31.5 hours. The prevalence of positive findings increases with the duration of exposure, interestingly, to a comparable degree in both animals and humans. Fig. 3 depicts positive and negative animal and human studies, as they relate to the maturational equivalency of the human brain during exposure. While preclinical studies predominantly focused on premature stages of brain development and clinical studies on postnatal stages, no distinct changes in the prevalence of positive studies were observed with increasing age, either in animals or in humans. While this would suggest that no clear age could be identified to be completely devoid of positive findings, the number of animal studies for maturational stages equivalent to children beyond one year of age was limited.

Discussion

Does anesthetic exposure harm the human brain?

Despite a rapidly evolving body of clinical and preclinical studies, it is currently impossible to answer this question with certainty. It remains unresolved whether cognitive abnormalities observed in clinical studies are caused by comorbidities, pain, inflammation, surgery, or genetic predisposition and are therefore merely associated with anesthetic exposures, rendering anesthesia as an indicator for children susceptible to neurological impairment, or whether anesthetics molecularly trigger abnormalities, representing causation. Importantly, the similarity in increasing prevalence of positive findings between human and animal studies and the structural abnormalities observed in a wide variety of animal species, including non-human primates, suggest that additional studies both in children utilizing more prolonged exposures, as well as animal studies with specifically targeted brain maturational equivalency, are urgently needed.

What are the structural abnormalities observed in animals, and has an exposure threshold been identified below which no injuries occur?

Brain tissue analysis in animals immediately following anesthetic exposure has found a variety of abnormalities, including downregulation of trophic and neurogenic factors [46,47], endocrine disruption [48], elimination and interference with the formation of synapses [49], alterations in dendritic arborization [50,51], impediment to formation of new neurons and their axonal growth [52], as well as diminished viability of brain cells, such as neurons [53], glial cells [54], and oligodendrocytes [55]. It is currently unclear whether all structural abnormalities are caused by the same mechanism and would therefore represent a continuum on a dose-response relationship or whether they are unrelated phenomena involving distinct molecular pathways. Even though there exists substantial heterogeneity in species, drugs, outcome measures, a cautious analysis, dichotomizing positive and negative results, suggests a dose/exposure time-response relationship, by demonstrating an increase in the number of studies finding a structural and/or functional deficit with increasing exposure times (Fig. 2). Importantly, however, widespread neuronal cell death has also been detected in mice following a 1-hour exposure to isoflurane [56] and in non-human primates following exposures as short as 3 hours [57], suggesting that some form of structural alteration more likely than not also occurs in children undergoing anesthetic exposures of prolonged duration. The functional relevance of these immediate structural changes, however, remains controversial and will be discussed in more detail below.

Does animal research demonstrate all general anesthetics to be similarly toxic or are some drugs safer to use than others?

Several studies have compared inhaled anesthetics with each other to establish whether one is safer to use than others, most frequently using neuronal cell death or dendritic alterations as the studied endpoints. Results have been conflicting, with some studies finding desflurane to cause more cell death than isoflurane or sevoflurane [58], while others found a lack of effect on dendritic spine density by desflurane [59]. One study demonstrated isoflurane to be more deleterious than desflurane [60], while another study showed isoflurane to cause greater neurodegeneration than sevoflurane, albeit without neurocognitive consequences [61]. In our laboratory, after establishing equal potencies, desflurane, isoflurane, and sevoflurane created comparable increases in executioner caspase-activation and indistinguishable rates of neuronal degeneration following 6-hour exposures, suggesting that none of the currently most frequently utilized volatile anesthetics can be recommended over others [62]. Studies using injectable anesthetics, such as ketamine, propofol, midazolam, or thiopental, are even more difficult to interpret, since continuous drug administration is challenging in small animals and doses based on body weight required to anesthetize small animals are exponentially higher than in humans and outside the range of clinical practice, due to biochemical and pharmacokinetic species differences. Moreover, no clearly superior injectable anesthetic has been identified. Most recently, the experimental neuroactive steroid 3β-OH has demonstrated anesthetic properties without neurotoxicity [63]. In summary, animal studies into comparable neurotoxicity have demonstrated widely conflicting results; therefore, no general anesthetic was consistently identified to be safer than others. Accordingly, no recommendations for clinical practice can be made for choosing one anesthetic agent over another. However, the sedative dexmedetomidine seems to cause substantially lower rates of neuronal demise than sevoflurane, even in higher doses [64]. While it doesn’t provide the same level of anesthesia compared with general anesthetics [64], dexmedetomidine could still be used to decrease the dose of injurious anesthetics and for neuroprotective purposes.

What might explain the specific vulnerability of the developing brain to the anesthetics’ deleterious effects?

The distinct vulnerability of very young animals demonstrated in numerous studies raises the question whether it is caused by the milieu in the young brain rendering all brain cells more susceptible to anesthetic side effects or rather if anesthetic drugs specifically target very distinct stages and signaling pathways during brain development, thereby triggering adverse effects in very defined cell populations. Further elucidating this question will be critically important for identifying potentially susceptible stages of human brain development, for developing targeted mitigation strategies, and for devising safer anesthetic techniques for patients of all ages. In this discussion, it is important to acknowledge that dramatic structural changes occur naturally in the developing brain, including massive brain cell death, which represents an integral part of normal brain development, as 50% of all neurons formed in the developing brain do not survive into adulthood. Work in our laboratory aimed at better delineating the maturational stage-specific vulnerability has identified the late progenitor/early immature neuronal stage as specifically susceptible to anesthesia-induced neuronal cell death (Fig. 4) [65]. Importantly, we were able to demonstrate that even in the developing brain, relatively mature neurons were not susceptible to neuronal cell death [65].
As a result, the observed degree of brain regional vulnerability varies in accordance with the extent of regional neurogenesis, rendering brain regions with earlier peaks in neurogenesis more vulnerable at an early age, while susceptibility of regions peaking at a later stage was concomitantly delayed (Fig. 5) [66]. Similarly, dendritic abnormalities during anesthetic exposure are highly dependent on the age during exposure [50].
These findings convincingly demonstrate that not all neurons are indiscriminately affected during anesthetic exposure, which would argue against the developing milieu being the culprit for structural changes. Rather, anesthetics seem to trigger or block developmentally encoded processes in neurons of a very specific stage of cellular development. In order to better instruct clinical care, it will be imperative to identify the equivalent cellular populations in young children to better delineate their role and fate in order to identify a clinical phenotype.

What are the long-term cognitive consequences of anesthetic exposure in immature animals and how do they relate to the immediate structural abnormalities?

While the brain structural abnormalities following prolonged anesthetic exposures in animals are dramatic and concerning, the functional consequences are probably of even greater translational relevance to pediatric anesthesia practice, since histological comparisons between animals and humans cannot be performed. However, this field of research is hindered by the differences in neurological performance among species. Several animal studies have evaluated spontaneous behavior, tested performance in memory tasks, or assessed response to stressors in adult animals exposed to anesthetics early in life and have repeatedly found abnormalities compared with unexposed controls [34,67–69]. However, an anesthesia-specific cognitive phenotype has yet to be identified, even in animals, and not all cognitive tasks testing similar neurological domains have consistently found deficiency, even within the same study [67]. Moreover, the immediate and long-term structural correlates underlying long-term cognitive abnormalities remain unclear. It seems compelling to attribute learning impairment in adult animals to neuronal deletion in brain regions utilized for learning and memory tasks, such as the hippocampus. However, we and others have found that extensive neuronal cell death can occur in immature mice immediately following anesthetic exposure in this region, without observing long-term spatial learning impairment [70]. This could be explained by the fact that in some animals even substantial cell death immediately following isoflurane exposure does not translate into long-term diminished neuronal densities [70,71]. Accordingly, permanent neuronal deletion and adult cognitive impairment were both found in rats following a neonatal exposure to isoflurane, nitrous oxide, and midazolam [67,72]. It is unclear whether differences in anesthetic regimens or species contributed to the discrepant findings. Another explanation could be that the total number of eliminated cells may not be the determining factor, but rather the effectiveness of the repair process, or that structural abnormalities of synapses or dendrites determine functional impairment, rather than cellular demise.
In summary, the structural correlate occurring immediately following neonatal anesthesia that underlies long-term cognitive abnormalities remains unresolved. Potential candidates may include neuronal cell death, synaptic dissolution, or dendritic abnormalities. However, it is unclear whether these have to be specific to a particular brain region. Resolving this conundrum will be critical in improving our understanding of the underlying mechanisms of anesthetic neurotoxicity and for devising mitigating strategies.

How do the vulnerable maturational phases observed in animals translate to human brain developmental stages and can an age be identified beyond which no injury occurs?

Since i) no biological tenet categorically exempts humans from the brain structural abnormalities observed following anesthetic exposures in animals and ii) structural abnormalities have been found to vary substantially with age and/or the maturational stage of the animal’s brain during exposure, it is imperative to better categorize the equivalent stages of human brain development compared with animal studies. Even though it is impossible to perform histological analyses in healthy human brain tissue equivalent to animal studies, for obvious ethical reasons, it seems more likely than not that some structural changes consistent with those observed in animals, including non-human primates, also occur in children undergoing prolonged anesthetic exposures. However, since it is unclear which structural abnormalities cause functional impairment or translate to human cognition, it is important to consider all abnormalities equally as potential candidates for cognitive or behavioral deficits in humans. Accordingly, Fig. 3 shows the prevalence of animal and human studies demonstrating any structural or functional abnormalities following anesthetic exposure, relative to the maturational equivalent state in humans. While brain development substantially differs in regional and temporal trajectories between humans and any other species and the analysis therefore represents somewhat of a generalization, this graph nonetheless illustrates that the developmental stages most frequently studied in animals correlate to immature phases of human brain development and less to older children. However, as an extension of our previous findings of developmental stage-dependent vulnerability, we were able to demonstrate in rodents that immature neurons in brain regions with ongoing neurogenesis, such as the olfactory bulb and hippocampus, are subject to isoflurane-induced neuronal cell death even into young adulthood, and potentially throughout life (Fig. 5) [66]. Other groups have similarly detected neuronal cell death following propofol exposure in the hippocampus of adult animals [73].
These findings convincingly demonstrate that detrimental effects of prolonged anesthetic exposure are not specific or limited to the immature brain, but also occur in the adolescent or young adult brain, albeit in different brain regions than in very young animals and to a different degree, making it impossible to advise clinical practice regarding a safe age beyond which prolonged anesthetic exposure will not cause any detrimental brain abnormalities. However, these findings nonetheless explain the profound vulnerability of the immature brain, due to its overabundance of immature neurons. Importantly, this would indicate that different neurological tasks could be targeted at different ages, specifically, during their developmental windows of acquisition, as it involves amplified neurogenesis, which exposes this amplified population of immature neurons to anesthesia-induced neurotoxicity. Interestingly, while it has frequently been assumed that exposures in infancy would be most prone to causing long-term brain developmental impairment, two recent large studies concluded that school readiness scores, as assessed with the Early Development Instrument in kindergarteners, were lower in children who had been exposed to anesthesia as toddlers between 2 and 4 years of age, but not in children exposed under 2 years of age [41,43]. This suggests that anesthetic exposures at different ages may lead to diverse neurological deficits, dependent on which neurological skills were being acquired during exposures. This may explain the equivocal results from human studies with diverse age groups and may also help explain the exaggerated effects of multiple exposures during different windows of vulnerability.

What is the current evidence for the effects of anesthetic exposures on the developing human brain and is it consistent with evidence obtained in animal studies?

Several studies have now been performed specifically examining the effects of anesthetic exposures early in life on subsequent behavior and cognitive performance in humans (most recently reviewed in [74]). The majority of these studies have been large- to medium-scale epidemiological studies, which due to their retrospective nature are unable to distinguish between the anesthetic exposure and perioperative physiological derangements, including blood pressure fluctuations, pain, inflammation, inadequate or excessive depths of anesthesia, or co-morbidities. Studies can broadly be divided into three categories, depending on their endpoints: those measuring academic achievement with group-administered tests, those using diagnoses of learning abnormalities or need for remedial services, and those employing individually administered neuropsychological tests [75]. Thus far, the field only includes one randomized controlled trial, the GAS study [38], which has not found any neurological abnormalities compared with a regional anesthetic technique, and two ambi-directional studies combining historical anesthetic exposures with prospective cognitive testing, the PANDA and MASK studies [39,45], which found no abnormalities compared with an unexposed siblings or unexposed peers, respectively, following a single anesthetic exposure. However, these single exposures were largely limited to under 1 hour and it remains questionable whether these results can be extrapolated to more prolonged exposures. Importantly, the MASK study’s multiple exposure group demonstrated processing speed and fine motor abnormalities as well as reported problems related to executive function, behavior, and reading following a median cumulative exposure time of greater than 3 hours [45]. Similarly, several other epidemiological studies have found repetitive and prolonged cumulative exposures for surgery early in life to lead to more frequent diagnosis of behavioral abnormalities, diminished academic achievement, and subpar performance in neurocognitive tests (Table 1).
In the frequently studied population of Olmsted County in Rochester, Minnesota, researchers at the Mayo Clinic have repeatedly demonstrated that multiple, but not single anesthetic exposures can increase the risk of learning disabilities [13,19]. Another birth cohort used to determine the long-term effects of anesthesia is the Western Australian Pregnancy Cohort (Raine), which demonstrated no diminution in academic achievement, but an increased risk for ICD-9-based diagnosis codes for cognitive and language disorders, as well as deficits in directly administered language tests following a single, prolonged exposure during the first three years of life [22,30,76,77]. Accordingly, our analysis found that the prevalence of brain structural or functional abnormalities increases with increased exposure times, both in animals and in humans (Fig. 2).

What are the similarities and important differences between humans and animals as they relate to long-term effects of anesthetics in the developing brain?

Animal studies, even in non-human primates, are fundamentally different from clinical pediatric anesthesia practice [78], as all animals are healthy subjects, whereas children requiring surgery and diagnostic studies with anesthesia oftentimes suffer from significant co-morbidities. Laboratory studies also very infrequently include painful stimulation or surgical trauma during exposure, which could potentially exacerbate or mitigate injury caused by anesthetics. Importantly, animals are frequently of very similar age during exposure and some rodent studies involve genetically identical subjects, while clinical practice accompanies high variability in genetic background and wide age ranges, which may significantly affect outcomes and complicates translational relevance of animal studies. While absolute doses for inhaled anesthetics utilized in animals are comparable to pediatric anesthesia, much higher doses of injectable anesthetics are required to anesthetize small animals compared with those used in clinical practice. Moreover, exposure times in the laboratory are frequently outside of the exposure durations seen during routine clinical practice and human studies. However, complicating these species comparisons of anesthetic durations is the question whether exposure times should be expressed as a fraction of life expectancy, or whether other comparison metrics, such as neuronal cell cycle, should be utilized. The former would result in substantially greater relative durations in small animals, due to their shorter life expectancy, whereas the latter renders exposures much more comparable between humans and animals.
Importantly, it remains challenging to equate brain maturational stages of study animals to the corresponding periods of human brain development. This is a crucial point, since animal studies have demonstrated age during exposure to critically affect regional distribution of structural abnormalities [50,65]. Moreover, more recent work in animals and the collation of clinical and preclinical literature here strongly suggest that abnormalities may occur in animals even after the equivalent stage for 3-year-old humans [66]. Accordingly, it is very conceivable that exposures during critical windows of brain development may affect different developmental milestones and therefore may result in different neurological phenotypes, dependent on the neurological skill under development. This important aspect has yet to be better addressed in clinical studies by investigating patient cohorts that are more homogeneous in their age during exposure.

What are the putative mechanisms underlying anesthetic neurotoxicity and the alleviating strategies tested in animals and can they be instantaneously implemented in clinical practice?

The exact mechanism of anesthesia-induced disruption of brain development remains undetermined. Accordingly, any alleviating strategy that has been tested to date may not specifically target the main neurotoxic mechanism or mitigate all deleterious effects, as different structural effects and functional abnormalities may be caused by different mechanisms. Moreover, the majority of strategies leading to diminished neuronal cell death immediately following exposure have not been tested regarding functional integrity later in life. At the same time, it is unclear which functional outcome in animals is most relevant for children undergoing anesthesia early in life. This represents a major obstacle to devising and testing mitigating approaches in children. Several hypotheses have been put forward on the mechanism underlying anesthetic neurotoxicity [79]; the most prevailing assumptions have been that the anesthetics’ NMDA receptor-blocking and GABAA receptor-stimulating properties may cause abnormal neuronal inhibition, which leads to immediate neuronal demise and long-term cognitive abnormalities due to an inadequate number of neurons in adulthood. Importantly, however, any causation of NMDA and GABA-mediated effects has never been conclusively demonstrated and several studies actually refute this proposed mechanism [80,81]. Other hypotheses for anesthetic neurotoxicity include that the stimulation of GABAA-receptors in immature cells may result in overexcitation; that an overactivation of inositol 1,4,5-trisphosphate receptors (InsP3Rs) may lead to excessive Ca2+ release from the endoplasmic reticulum; prolonged NMDA receptor blockade may upregulate glutamate receptor NR1 subunits, facilitating pathological calcium entry into neurons; anesthesia-induced reductions in synaptic tissue plasminogen activation (tPA) release and increases in proBDNF/p75NTR might mediate apoptotic cell death; disruption of the neuronal cytoskeleton could lead to cellular dysfunction and death; impairment in synapse formation; and disturbance of mitochondrial metabolism may lead to anesthesia-induced neuronal cell death. Accordingly, a widely disparate array of drugs and compounds has been tested and demonstrated to avert anesthesia-induced neurotoxicity, such as lithium, melatonin, bumetanide, pilocarpine, estradiol, neurotrophic receptor p75NTR, vitamin C, L-carnitine, coenzyme Q10, resveratrol, pramipexole, carbon monoxide, hydrogen gas, xenon, and dexmedetomidine, to name a few. Whole body hypothermia to 24°C was also found to diminish neuronal cell death during anesthetic exposure. In general, since the majority of therapies employed in animals have not been thoroughly tested in children yet and because human applicability of animal data is still under investigation, none of these modalities can currently be recommended for routine clinical practice.

Are there any gender differences in response to anesthetic exposure in animals or humans?

Beginning in childhood and leading into adolescence, brain maturation differs significantly between sexes [82]. Accordingly, several animal studies have investigated whether gender differences exist in the response to anesthetic exposures. Some rodent studies have found learning and social behavior abnormalities [83,84] and neurobehavioral and endocrine abnormalities [48,85] subsequent to neonatal exposure to isoflurane, sevoflurane, or propofol only in male rats, but not female animals. Conversely, however, other groups demonstrated greater vulnerability in female animals, such as more acute structural damage [86], and altered adult motor activity [87], as well as adult spatial learning impairment [88]. Yet other studies have not detected any sex-related differences, such as emotional reactivity in rhesus macaque monkeys [89]. Similarly, studies in our laboratory have not found any gender differences during a complex learning task involving the Morris water maze in adult mice exposed to 6 hours of isoflurane early in life [70].
Clinical investigations into anesthetic exposures inevitably more frequently study male subjects, because boys more commonly require surgery in early childhood. Boys who underwent anesthesia in infancy, but not girls, performed worse in a long-term spatial recollection memory task, compared with unexposed gender-matched children [34]. Following neonatal cardiac surgery with general anesthesia, male gender represents a risk factor for lower mental performance in the Bailey Scales of Infant Development [90]. Importantly, however, in the general population, speech and language delay as well as mental illness are more frequently diagnosed in males, compared with females [91,92], and premature male infants have worse outcomes compared with those of female gender [93]. It is therefore currently unclear, both in laboratory studies as well as in clinical practice, whether gender differences exist in the brain’s response to anesthetic exposure.

Should anesthesiologists proactively inform parents about this clinical concern?

Given the warning expressed in the United States regarding the prolonged or repeated use of anesthetics for greater than 3 hours in children younger than 3 years of age, it may be required or encouraged by local jurisdictions for anesthesia providers to proactively inform parents of the concerns regarding the prolonged use of anesthetics in young children. Moreover, there may exist an ethical obligation to include pertinent information in an informed consent for general anesthesia. On the other hand, it can be argued that the lack of definitive data unequivocally and causatively linking anesthetic exposures in isolation of other stressors to neurological impairment does not warrant discussion prior to medically indicated procedures, as it would cause parents undue distress and create unjustifiable conflict whether to proceed with a required intervention out of concern for the potential risks of anesthetic effects. Accordingly, it should probably currently remain at the particular anesthesiologist’s discretion whether or not to proactively address the potential long-term effects of anesthetic exposure on brain development with parents.

How should anesthesiologists address concerns regarding the use of anesthetics in children, when raised by parents?

When approached by parents, anesthesiologists should be prepared to discuss this topic in detail with the concerned guardians. This can only be accomplished if providers stay abreast of this rapidly evolving field. Obviously, not performing a necessary procedure may expose the child to substantial risks for loss of life or injury, far outweighing the concerns regarding anesthetic exposure on brain development. Parents should understand that current animal research does not justify postponing exposures until a certain age, as no safe age has been clearly identified yet. Rather, evolving animal and human research support differential effects at different ages and stages of brain development. Moreover, the best clinical evidence currently available from the GAS and PANDA studies suggests that a single, approximately 1-hour anesthetic exposure very early in life may not have any measurable effects on subsequent cognitive performance in young toddlers [38,39]. However, since these studies did not address prolonged or repeated exposure, the same statement can currently not be made with certainty regarding in these scenarios. It therefore remains important to minimize the number of procedures and exposure times as much as feasible. It is also important to note that a variety of factors, including educational experiences, probably have a greater effect on brain development than anesthetic exposures. All health care professionals involved in caring for a particular child should be included in any discussion regarding indication and timing of procedures requiring general anesthesia. Parental concerns should not be hastily dismissed, but should be put in the nuanced context of evolving research in a complex field. Continued research is urgently needed to better define the phenomenon, to understand its mechanisms, and to devise strategies to improve perioperative safety for children requiring lifesaving and quality of life improving procedures early in life.

Conclusions

This review finds that there currently exist more than 530 animal studies and greater than 30 clinical studies specifically investigating the effects of anesthetic exposure on the developing brain in this rapidly developing field of research. While emerging clinical studies suggest that anesthetic exposures up to 1 hour do not cause measurable abnormalities later in life, the current pre-clinical and limited clinical evidence are surprisingly consistent in demonstrating an increasing prevalence of abnormal findings with increasing exposure times. Importantly, current animal research does not support a specific exposure threshold below which no structural injury occurs. Moreover, despite the sizable body of literature, no particular anesthetic has been consistently identified to be less injurious than others to be recommended for use as a general anesthetic in young children. Animal and human data do not clearly identify a specific age beyond which anesthetic exposures are devoid of subsequent potential neurological abnormalities. This paucity of definitive information currently precludes any evidence-based recommendations for drastic changes in clinical practice and calls for concerted laboratory and clinical research efforts to further improve the safety of perioperative care for thousands of young children requiring life-saving and quality of life-improving procedures every day.

Notes

Funding Statement

National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (2017R1A2B4004803).

References

1. Soriano SG, Loepke AW. Let's not throw the baby out with the bath water: potential neurotoxicity of anesthetic drugs in infants and children. J Neurosurg Anesthesiol. 2005; 17:207–9.
2. Jevtovic-Todorovic V, Olney JW. PRO: Anesthesia-induced developmental neuroapoptosis: status of the evidence. Anesth Analg. 2008; 106:1659–63.
crossref
3. Loepke AW, McGowan FX Jr, Soriano SG. CON: The toxic effects of anesthetics in the developing brain: the clinical perspective. Anesth Analg. 2008; 106:1664–9.
crossref
4. Vutskits L. Anesthetic-related neurotoxicity and the developing brain: shall we change practice? Paediatr Drugs. 2012; 14:13–21.
5. Davidson AJ. Neurotoxicity and the need for anesthesia in the newborn: does the emperor have no clothes? Anesthesiology. 2012; 116:507–9.
6. FDA drug safety communication: FDA approves label changes for use of general anesthetic and sedation drugs in young children [Internet]. Silver Spring (MD): U.S. Food & Drug Administration;2017. Apr. 27. [updated 2017 May 9; cited 2018 Jun 19]. Available from www.fda.gov/Drugs/DrugSafety/ucm554634.htm.
7. Lin EP, Lee JR, Lee CS, Deng M, Loepke AW. Do anesthetics harm the developing human brain? An integrative analysis of animal and human studies. Neurotoxicol Teratol. 2017; 60:117–28.
crossref
8. Clancy B, Darlington RB, Finlay BL. Translating developmental time across mammalian species. Neuroscience. 2001; 105:7–17.
crossref
9. Clancy B, Finlay BL, Darlington RB, Anand KJ. Extrapolating brain development from experimental species to humans. Neurotoxicology. 2007; 28:931–7.
crossref
10. Workman AD, Charvet CJ, Clancy B, Darlington RB, Finlay BL. Modeling transformations of neurodevelopmental sequences across mammalian species. J Neurosci. 2013; 33:7368–83.
crossref
11. Rozé JC, Denizot S, Carbajal R, Ancel PY, Kaminski M, Arnaud C, et al. Prolonged sedation and/or analgesia and 5-year neurodevelopment outcome in very preterm infants: results from the EPIPAGE cohort. Arch Pediatr Adolesc Med. 2008; 162:728–33.
12. Kalkman CJ, Peelen L, Moons KG, Veenhuizen M, Bruens M, Sinnema G, et al. Behavior and development in children and age at the time of first anesthetic exposure. Anesthesiology. 2009; 110:805–12.
crossref
13. Wilder RT, Flick RP, Sprung J, Katusic SK, Barbaresi WJ, Mickelson C, et al. Early exposure to anesthesia and learning disabilities in a population-based birth cohort. Anesthesiology. 2009; 110:796–804.
crossref
14. Sprung J, Flick RP, Wilder RT, Katusic SK, Pike TL, Dingli M, et al. Anesthesia for cesarean delivery and learning disabilities in a populationbased birth cohort. Anesthesiology. 2009; 111:302–10.
crossref
15. DiMaggio C1, Sun LS, Kakavouli A, Byrne MW, Li G. A retrospective cohort study of the association of anesthesia and hernia repair surgery with behavioral and developmental disorders in young children. J Neurosurg Anesthesiol. 2009; 21:286–91.
crossref
16. Bartels M, Althoff RR, Boomsma DI. Anesthesia and cognitive performance in children: no evidence for a causal relationship. Twin Res Hum Genet. 2009; 12:246–53.
crossref
17. DiMaggio C, Sun LS, Li G. Early childhood exposure to anesthesia and risk of developmental and behavioral disorders in a sibling birth cohort. Anesth Analg. 2011; 113:1143–51.
crossref
18. Flick RP, Lee K, Hofer RE, Beinborn CW, Hambel EM, Klein MK, et al. Neuraxial labor analgesia for vaginal delivery and its effects on childhood learning disabilities. Anesth Analg. 2011; 112:1424–31.
crossref
19. Flick RP, Katusic SK, Colligan RC, Wilder RT, Voigt RG, Olson MD, et al. Cognitive and behavioral outcomes after early exposure to anesthesia and surgery. Pediatrics. 2011; 128:e1053–61.
crossref
20. Guerra GG, Robertson CM, Alton GY, Joffe AR, Cave DA, Dinu IA, et al. Neurodevelopmental outcome following exposure to sedative and analgesic drugs for complex cardiac surgery in infancy. Paediatr Anaesth. 2011; 21:932–41.
21. Hansen TG, Pedersen JK, Henneberg SW, Pedersen DA, Murray JC, Morton NS, et al. Academic performance in adolescence after inguinal hernia repair in infancy: a nationwide cohort study. Anesthesiology. 2011; 114:1076–85.
22. Ing C, DiMaggio C, Whitehouse A, Hegarty MK, Brady J, von Ungern-Sternberg BS, et al. Long-term differences in language and cognitive function after childhood exposure to anesthesia. Pediatrics. 2012; 130:e476–85.
crossref
23. Block RI, Thomas JJ, Bayman EO, Choi JY, Kimble KK, Todd MM. Are anesthesia and surgery during infancy associated with altered academic performance during childhood? Anesthesiology. 2012; 117:494–503.
crossref
24. Filan PM, Hunt RW, Anderson PJ, Doyle LW, Inder TE. Neurologic outcomes in very preterm infants undergoing surgery. J Pediatr. 2012; 160:409–14.
crossref
25. Bong CL, Allen JC, Kim JT. The effects of exposure to general anesthesia in infancy on academic performance at age 12. Anesth Analg. 2013; 117:1419–28.
crossref
26. Hansen TG, Pedersen JK, Henneberg SW, Morton NS, Christensen K. Educational outcome in adolescence following pyloric stenosis repair before 3 months of age: a nationwide cohort study. Paediatr Anaesth. 2013; 23:883–90.
27. Fan Q, Cai Y, Chen K, Li W. Prognostic study of sevoflurane-based general anesthesia on cognitive function in children. J Anesth. 2013; 27:493–9.
crossref
28. Andropoulos DB, Ahmad HB, Haq T, Brady K, Stayer SA, Meador MR, et al. The association between brain injury, perioperative anesthetic exposure, and 12-month neurodevelopmental outcomes after neonatal cardiac surgery: a retrospective cohort study. Paediatr Anaesth. 2014; 24:266–74.
crossref
29. Garcia Guerra G, Robertson CM, Alton GY, Joffe AR, Cave DA, Yasmin F, et al. Neurotoxicity of sedative and analgesia drugs in young infants with congenital heart disease: 4-year follow-up. Paediatr Anaesth. 2014; 24:257–65.
crossref
30. Ing CH, DiMaggio CJ, Malacova E, Whitehouse AJ, Hegarty MK, Feng T, et al. Comparative analysis of outcome measures used in examining neurodevelopmental effects of early childhood anesthesia exposure. Anesthesiology. 2014; 120:1319–32.
crossref
31. Yan J, Li YR, Zhang Y, Lu Y, Jiang H. Repeated exposure to anesthetic ketamine can negatively impact neurodevelopment in infants: a prospective preliminary clinical study. J Child Neurol. 2014; 29:1333–8.
32. Ko WR, Liaw YP, Huang JY, Zhao DH, Chang HC, Ko PC, et al. Exposure to general anesthesia in early life and the risk of attention deficit/hyperactivity disorder development: a nationwide, retrospective matched-cohort study. Paediatr Anaesth. 2014; 24:741–8.
crossref
33. Ko WR, Huang JY, Chiang YC, Nfor ON, Ko PC, Jan SR, et al. Risk of autistic disorder after exposure to general anaesthesia and surgery: a nationwide, retrospective matched cohort study. Eur J Anaesthesiol. 2015; 32:303–10.
34. Stratmann G, Lee J, Sall JW, Lee BH, Alvi RS, Shih J, et al. Effect of general anesthesia in infancy on long-term recognition memory in humans and rats. Neuropsychopharmacology. 2014; 39:2275–87.
crossref
35. Taghon TA, Masunga AN, Small RH, Kashou NH. A comparison of functional magnetic resonance imaging findings in children with and without a history of early exposure to general anesthesia. Paediatr Anaesth. 2015; 25:239–46.
crossref
36. Chien LN, Lin HC, Shao YH, Chiou ST, Chiou HY. Risk of autism associated with general anesthesia during cesarean delivery: a population-based birth-cohort analysis. J Autism Dev Disord. 2015; 45:932–42.
crossref
37. Backeljauw B, Holland SK, Altaye M, Loepke AW. Cognition and brain structure following early childhood surgery with anesthesia. Pediatrics. 2015; 136:e1–12.
crossref
38. Davidson AJ, Disma N, de Graaff JC, Withington DE, Dorris L, Bell G, et al. Neurodevelopmental outcome at 2 years of age after general anaesthesia and awake-regional anaesthesia in infancy (GAS): an international multicentre, randomised controlled trial. Lancet. 2016; 387:239–50.
crossref
39. Sun LS, Li G, Miller TL, Salorio C, Byrne MW, Bellinger DC, et al. Association between a single general anesthesia exposure before age 36 months and neurocognitive outcomes in later childhood. JAMA. 2016; 315:2312–20.
crossref
40. Clausen NG, Pedersen DA, Pedersen JK, Møller SE, Grosen D, Wehby GL, et al. Oral clefts and academic performance in adolescence: the impact of anesthesia-related neurotoxicity, timing of surgery, and type of oralclefts. Cleft Palate Craniofac J. 2017; 54:371–80.
41. O'Leary JD, Janus M, Duku E, Wijeysundera DN, To T, Li P, et al. A population-based study evaluating the association between surgery in early life and child development at primary school entry. Anesthesiology. 2016; 125:272–9.
42. Doberschuetz N, Dewitz R, Rolle U, Schlösser R, Allendorf A. Follow-up of children with gastrointestinal malformations and postnatal surgery and anesthesia: evaluation at two years of age. Neonatology. 2016; 110:8–13.
crossref
43. Graham MR, Brownell M, Chateau DG, Dragan RD, Burchill C, Fransoo RR. Neurodevelopmental assessment in kindergarten in children exposed to general anesthesia before the age of 4 years: a retrospective matchedcohort study. Anesthesiology. 2016; 125:667–77.
44. Glatz P, Sandin RH, Pedersen NL, Bonamy AK, Eriksson LI, Granath F. Association of anesthesia and surgery during childhood with long-term academic performance. JAMA Pediatr. 2017; 171:e163470.
crossref
45. Warner DO, Zaccariello MJ, Katusic SK, Schroeder DR, Hanson AC, Schulte PJ, et al. Neuropsychological and behavioral outcomes after exposure of young children to procedures requiring general anesthesia: the mayo anesthesia safety in kids (MASK) study. Anesthesiology. 2018; 129:89–105.
46. Lu LX, Yon JH, Carter LB, Jevtovic-Todorovic V. General anesthesia activates BDNF-dependent neuroapoptosis in the developing rat brain. Apoptosis. 2006; 11:1603–15.
crossref
47. Head BP, Patel HH, Niesman IR, Drummond JC, Roth DM, Patel PM. Inhibition of p75 neurotrophin receptor attenuates isoflurane-mediated neuronal apoptosis in the neonatal central nervous system. Anesthesiology. 2009; 110:813–25.
48. Tan S, Xu C, Zhu W, Willis J, Seubert CN, Gravenstein N, et al. Endocrine and neurobehavioral abnormalities induced by propofol administered to neonatal rats. Anesthesiology. 2014; 121:1010–7.
crossref
49. Sanchez V, Feinstein SD, Lunardi N, Joksovic PM, Boscolo A, Todorovic SM, et al. General anesthesia causes long-term impairment of mitochondrial morphogenesis and synaptic transmission in developing rat brain. Anesthesiology. 2011; 115:992–1002.
crossref
50. De Roo M, Klauser P, Briner A, Nikonenko I, Mendez P, Dayer A, et al. Anesthetics rapidly promote synaptogenesis during a critical period of brain development. PLoS One. 2009; 4:e7043.
crossref
51. Lunardi N, Ori C, Erisir A, Jevtovic-Todorovic V. General anesthesia causes long-lasting disturbances in the ultrastructural properties of developing synapses in young rats. Neurotox Res. 2010; 17:179–88.
crossref
52. Mintz CD, Smith SC, Barrett KM, Benson DL. Anesthetics interfere with the polarization of developing cortical neurons. J Neurosurg Anesthesiol. 2012; 24:368–75.
crossref
53. Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vöckler J, Dikranian K, et al. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science. 1999; 283:70–4.
crossref
54. Lunardi N, Hucklenbruch C, Latham JR, Scarpa J, Jevtovic-Todorovic V. Isoflurane impairs immature astroglia development in vitro: the role of actin cytoskeleton. J Neuropathol Exp Neurol. 2011; 70:281–91.
crossref
55. Brambrink AM, Back SA, Riddle A, Gong X, Moravec MD, Dissen GA, et al. Isoflurane-induced apoptosis of oligodendrocytes in the neonatal primate brain. Ann Neurol. 2012; 72:525–35.
crossref
56. Johnson SA, Young C, Olney JW. Isoflurane-induced neuroapoptosis in the developing brain of nonhypoglycemic mice. J Neurosurg Anesthesiol. 2008; 20:21–8.
crossref
57. Noguchi KK, Johnson SA, Dissen GA, Martin LD, Manzella FM, Schenning KJ, et al. Isoflurane exposure for three hours triggers apoptotic cell death in neonatal macaque brain. Br J Anaesth. 2017; 119:524–31.
crossref
58. Kodama M, Satoh Y, Otsubo Y, Araki Y, Yonamine R, Masui K, et al. Neonatal desflurane exposure induces more robust neuroapoptosis than do isoflurane and sevoflurane and impairs working memory. Anesthesiology. 2011; 115:979–91.
crossref
59. Briner A, De Roo M, Dayer A, Muller D, Habre W, Vutskits L. Volatile anesthetics rapidly increase dendritic spine density in the rat medial prefrontal cortex during synaptogenesis. Anesthesiology. 2010; 112:546–56.
crossref
60. Tao G, Xue Q, Luo Y, Li G, Xia Y, Yu B. Isoflurane is more deleterious to developing brain than desflurane: the role of the akt/gsk3β signaling pathway. Biomed Res Int. 2016; 2016:7919640.
61. Liang G, Ward C, Peng J, Zhao Y, Huang B, Wei H. Isoflurane causes greater neurodegeneration than an equivalent exposure of sevoflurane in the developing brain of neonatal mice. Anesthesiology. 2010; 112:1325–34.
crossref
62. Istaphanous GK, Howard J, Nan X, Hughes EA, McCann JC, McAuliffe JJ, et al. Comparison of the neuroapoptotic properties of equipotent anesthetic concentrations of desflurane, isoflurane, or sevoflurane in neonatal mice. Anesthesiology. 2011; 114:578–87.
crossref
63. Atluri N, Joksimovic SM, Oklopcic A, Milanovic D, Klawitter J, Eggan P, et al. A neurosteroid analogue with T-type calcium channel blocking properties is an effective hypnotic, but is not harmful to neonatal rat brain. Br J Anaesth. 2018; 120:768–778.
crossref
64. Lee JR, Lin EP, Hofacer RD, Upton B, Lee SY, Ewing L, et al. Alternative technique or mitigating strategy for sevoflurane-induced neurodegeneration: a randomized controlled dose-escalation study of dexmedetomidine in neonatal rats. Br J Anaesth. 2017; 119:492–505.
crossref
65. Hofacer RD, Deng M, Ward CG, Joseph B, Hughes EA, Jiang C, et al. Cell age-specific vulnerability of neurons to anesthetic toxicity. Ann Neurol. 2013; 73:695–704.
crossref
66. Deng M, Hofacer RD, Jiang C, Joseph B, Hughes EA, Jia B, et al. Brain regional vulnerability to anaesthesia-induced neuroapoptosis shifts with age at exposure and extends into adulthood for some regions. Br J Anaesth. 2014; 113:443–51.
crossref
67. Jevtovic-Todorovic V, Hartman RE, Izumi Y, Benshoff ND, Dikranian K, Zorumski CF, et al. Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J Neurosci. 2003; 23:876–82.
crossref
68. Alvarado MC, Murphy KL, Baxter MG. Visual recognition memory is impaired in rhesus monkeys repeatedly exposed to sevoflurane in infancy. Br J Anaesth. 2017; 119:517–23.
crossref
69. Coleman K, Robertson ND, Dissen GA, Neuringer MD, Martin LD, Cuzon Carlson VC, et al. Isoflurane anesthesia has long-term consequences on motor and behavioral development in infant rhesus macaques. Anesthesiology. 2017; 126:74–84.
crossref
70. Loepke AW, Istaphanous GK, McAuliffe JJ 3rd, Miles L, Hughes EA, McCann JC, et al. The effects of neonatal isoflurane exposure in mice on brain cell viability, adult behavior, learning, and memory. Anesth Analg. 2009; 108:90–104.
crossref
71. Jiang Y, Tong D, Hofacer RD, Loepke AW, Lian Q, Danzer SC. Long-term fate mapping to assess the impact of postnatal isoflurane exposure on hippocampal progenitor cell productivity. Anesthesiology. 2016; 125:1159–70.
crossref
72. Nikizad H, Yon JH, Carter LB, Jevtovic-Todorovic V. Early exposure to general anesthesia causes significant neuronal deletion in the developing rat brain. Ann N Y Acad Sci. 2007; 1122:69–82.
crossref
73. Krzisch M, Sultan S, Sandell J, Demeter K, Vutskits L, Toni N. Propofol anesthesia impairs the maturation and survival of adult-born hippocampal neurons. Anesthesiology. 2013; 118:602–10.
crossref
74. Davidson AJ, Sun LS. Clinical evidence for any effect of anesthesia on the developing brain. Anesthesiology. 2018; 128:840–53.
crossref
75. Lei SY, Hache M, Loepke AW. Clinical research into anesthetic neurotoxicity: does anesthesia cause neurological abnormalities in humans? J Neurosurg Anesthesiol. 2014; 26:349–57.
76. Ing C, Hegarty MK, Perkins JW, Whitehouse AJO, DiMaggio CJ, Sun M, et al. Duration of general anaesthetic exposure in early childhood and long-term language and cognitive ability. Br J Anaesth. 2017; 119:532–40.
crossref
77. Ing C, Sun M, Olfson M, DiMaggio CJ, Sun LS, Wall MM, et al. Age at exposure to surgery and anesthesia in children and associationwith mental disorder diagnosis. Anesth Analg. 2017; 125:1988–98.
78. Mintz CD, Wagner M, Loepke AW. Preclinical research into the effects of anesthetics on the developing brain: promises and pitfalls. J Neurosurg Anesthesiol. 2012; 24:362–7.
79. Vutskits L, Xie Z. Lasting impact of general anaesthesia on the brain: mechanisms and relevance. Nat Rev Neurosci. 2016; 17:705–17.
crossref
80. Braun S, Gaza N, Werdehausen R, Hermanns H, Bauer I, Durieux ME, et al. Ketamine induces apoptosis via the mitochondrial pathway in human lymphocytes and neuronal cells. Br J Anaesth. 2010; 105:347–54.
crossref
81. Sanders RD, Xu J, Shu Y, Januszewski A, Halder S, Fidalgo A, et al. Dexmedetomidine attenuates isoflurane-induced neurocognitive impairment in neonatal rats. Anesthesiology. 2009; 110:1077–85.
crossref
82. De Bellis MD, Keshavan MS, Beers SR, Hall J, Frustaci K, Masalehdan A, et al. Sex differences in brain maturation during childhood and adolescence. Cereb Cortex. 2001; 11:552–7.
crossref
83. Rothstein S, Simkins T, Nuñez JL. Response to neonatal anesthesia: effect of sex on anatomical and behavioral outcome. Neuroscience. 2008; 152:959–69.
crossref
84. Lee BH, Chan JT, Kraeva E, Peterson K, Sall JW. Isoflurane exposure in newborn rats induces long-term cognitive dysfunction in males but not females. Neuropharmacology. 2014; 83:9–17.
crossref
85. Xu C, Tan S, Zhang J, Seubert CN, Gravenstein N, Sumners C, et al. Anesthesia with sevoflurane in neonatal rats: developmental neuroendocrine abnormalities and alleviating effects of the corticosteroid and Cl(-) importer antagonists. Psychoneuroendocrinology. 2015; 60:173–81.
crossref
86. Jevtovic-Todorovic V, Wozniak DF, Benshoff ND, Olney JW. A comparative evaluation of the neurotoxic properties of ketamine and nitrous oxide. Brain Res. 2001; 895:264–7.
crossref
87. Aligny C, Roux C, Dourmap N, Ramdani Y, Do-Rego JC, Jégou S, et al. Ketamine alters cortical integration of GABAergic interneurons and induces long-term sex-dependent impairments in transgenic Gad67-GFP mice. Cell Death Dis. 2014; 5:e1311.
crossref
88. Boscolo A, Ori C, Bennett J, Wiltgen B, Jevtovic-Todorovic V. Mitochondrial protectant pramipexole prevents sex-specific long-term cognitive impairment from early anaesthesia exposure in rats. Br J Anaesth. 2013; 110 Suppl 1:i47–52.
crossref
89. Raper J, Alvarado MC, Murphy KL, Baxter MG. Multiple anesthetic exposure in infant monkeys alters emotional reactivity to an acute stressor. Anesthesiology. 2015; 123:1084–92.
crossref
90. Gaynor JW, Stopp C, Wypij D, Andropoulos DB, Atallah J, Atz AM, et al. Neurodevelopmental outcomes after cardiac surgery in infancy. Pediatrics. 2015; 135:816–25.
crossref
91. McAlpine DD, Mechanic D. Utilization of specialty mental health care among persons with severe mental illness: the roles of demographics, need, insurance, and risk. Health Serv Res. 2000; 35:277–92.
92. Nelson HD, Nygren P, Walker M, Panoscha R. Screening for speech and language delay in preschool children: systematic evidence review for the US Preventive Services Task Force. Pediatrics. 2006; 117:e298–319.
crossref
93. Samsom JF, de Groot L, Cranendonk A, Bezemer D, Lafeber HN, Fetter WP. Neuromotor function and school performance in 7-year-old children born as high-risk preterm infants. J Child Neurol. 2002; 17:325–32.
crossref

Fig. 1.
Research articles investigating the effects of anesthetic exposure on the developing animal brain and commentaries have increased significantly over the past 48 years. The number of animal studies (filled black circles), as well as review articles, editorial views, commentaries, opinion papers, and correspondence on this topic (unfilled red circles) that have been published annually, as identified in a literature search using PubMed and Scopus databases, are shown spanning from 1974 until 2017.
kja-d-18-00165f1.tif
Fig. 2.
The majority of in vivo animal studies on the effects of anesthetic exposure on brain structure and function examine exposure times greater than occurring during routine clinical care. However, the prevalence of both animal and human studies returning positive findings, thereby suggesting potential injury, increases similarly with exposure time. Animal studies reporting abnormal findings are depicted above the horizontal line and negative findings are shown below the horizontal line, for both brain structural (red filled circles) or cognitive outcomes (blue filled circles), as a function of exposure time. Purple filled circles represent clinical studies into long-term cognitive outcomes in humans demonstrating abnormalities (above horizontal line) or no abnormalities (below horizontal line). Exposure times denote all reported anesthetic durations, either single or cumulative, or estimated exposure times based on injection schema, as described in the methods; accordingly, only studies reporting exposure times or injection schemata were included in the analysis. For the purpose of analysis, results are reported separately for each condition or outcome studied, and therefore single studies may be represented by multiple data points. Graphs express the ratio of positive to negative studies in animals (black) and humans (purple); open circles represent percentage of positive studies for respective exposure epochs between data points. Positive studies outnumber negative studies for all exposure times in both animals and humans, except for anesthetic exposures of 1 hour or less.
kja-d-18-00165f2.tif
Fig. 3.
The majority of in vivo animal studies on the effects of anesthetic exposure on brain structure and function focus on brain developmental stages equivalent to premature neonates. For animals, prevalence of positive studies outnumber negative studies for all age brackets, suggesting that no age can be clearly identified at which anesthetics do not cause abnormalities. Animal studies reporting abnormal findings are depicted above the horizontal line and negative findings are shown below the horizontal line, for both brain structural (red filled circles) and cognitive outcomes (blue filled circles), as a function of maturational age of the animals’ brain relative to the human brain during exposure. Purple filled circles represent clinical studies into long-term cognitive outcomes in humans. The animals’ age during exposure was converted to the corresponding maturational stage of the human brain based on a computational neurodevelopmental model [8-10] (www.translatingtime.net, translating ‘neurogenesis’ for ‘whole brain,’ last accessed 4/1/2018). For the purpose of analysis, reports with separate anesthetic protocols consisting of different anesthetic regimens or multiple exposure times of the same anesthetic were classified as separate studies. For repeated exposures at different ages, the equivalent mean age of the human brain is reported. Graphs express the ratio of positive to negative studies in animals (black) or humans (purple); open circles represent the respective percentage of positive studies for age epochs ranging from specific data points to the next lower data point on the graph.
kja-d-18-00165f3.tif
Fig. 4.
Neurons during intermediate stages of their development are specific targets of anesthesia-induced apoptosis During the continuum of neuronal maturation in the dentate gyrus, a brain region with life-long neurogenesis in rodents, isoflurane triggers apoptotic cell death in neuroblasts and immature neurons residing in the neurogenic niche, the subgranular zone (SGZ), but not in more immature radial-glial type and type II progenitors, or in mature neurons, which reside in the granule cell layer (GCL) and extend dendrites into the molecular layer (ML). Data are derived from Hofacer et al. [65]. The illustration depicts five representative stages of neuronal maturation throughout the life cycle from a pluripotent radial-glial type progenitor cell on the left to a postmitotic, mature neuron on the right. Cells at these various stages coexist in the postnatal dentate gyrus.
kja-d-18-00165f4.tif
Fig. 5.
Brain regional vulnerability to anesthesia-induced neuroapoptosis changes with age during exposure. Graphs indicate the relative increase in neuronal cell death observed at three different ages following isoflurane exposure, relative to physiological apoptotic cell death observed in littermate controls. Apoptotic neuronal density was quantified in superficial layers II/III of the retrosplenial agranular cortex (RSA), caudoputamen (CPu), the pyramidal layer of cornu ammonis 1 (CA1), cerebellum (Cb at P7, CB wm at P21), the subgranular zone and granule cell layer of dentate gyrus (DG), and the granule layer of the olfactory bulb (GrO) after a 6 h exposure to 1.5% isoflurane in newborn (P7), juvenile (P21), and adult mice (P49), compared with fasted, unanesthetized littermates [66]. Maximum vulnerability was observed in the neocortex, caudoputamen, and cornu ammonis 1 at P7, whereas the number of vulnerable neurons peaked at P21 for the cerebellum, dentate gyrus, and granule layer of the olfactory bulb. The murine brain’s maturational stage at P7 approximates the premature human brain, at P21 the infant brain, and at P49 the older child’s or adolescent brain [10]. *P < 0.05, †P < 0.01, ‡P < 0.001 compared with control. Adapted from Deng et al. [66].
kja-d-18-00165f5.tif
Table 1.
Clinical Research Studies Investigating the Effects of Anesthesia in Early Childhood on Long-term Neurocognitive Function
Study population (calendar years of birth or treatment) Study group (s)/Control group Anesthetic drugs Duration of exposure Number of subjects/controls Age during exposure Age during assessment Neurological assessment tools Neurological abnormalities observed in study group Reference
Prospective treatment cohort (1997) Prolonged sedation and/or analgesia for intensive care vs. no exposure to sedation or analgesia No data Not specified 97 exposed vs. 1,248 controls Neonatal period in premature infants born 22-32 weeks PCA 5 years MPC No difference in disability after adjustment for severity of illness; study lacked power to detect < 10% difference Rozé et al. [11]
Retrospective treatment cohort (1987, 1991, 1993, 1995) General anesthesia for urological procedures before 24 months vs. after 24 months of age No data Not specified 178 under, 65 > 24 months 0-6 years > 4 years CBCL/4–18 Incidence of behavioral disturbances higher in children operated on < 24 months of age, compared with > 24 months, but not statistically significant Kalkman et al. [12]
Birth cohort (1976-1982) General anesthesia before age 4 vs. no anesthetic exposure Predominantly halothane, nitrous oxide, ketamine, and/or thiopental; doses not quantified, stratified by number of exposures for mostly ENT and general surgery 125 ± 227 min median (IQR) 75 (45–120) 593 exposed vs. 4,764 controls 0-4 years, most 2 years ≤ 19 years Review of medical and educational records several years after exposure Doubling of the risk of learning disabilities following 2 or more surgical procedures with anesthesia for more than a combined 2 hours, compared with no or one exposure Wilder et al. [13]
Birth cohort (1976-1982) General anesthesia vs. regional anesthesia for cesarean delivery vs. spontaneous vaginal birth Predominantly sodium thiopental, nitrous oxide, and halothane; doses not specified Median 14 min (IQR 8-23) 5,320 At birth ≤ 19 years Review of school/educational records Similar incidence of learning disabilities among children delivered vaginally without anesthesia and via cesarean section with general anesthesia, but lower following cesarean section with regional anesthesia Sprung et al. [14]
Birth cohort (1999-2001) ICD-9 code for Inguinal hernia repair vs. absence of code No data Not specified 383 exposed vs. 5,050 controls 0–3 years ≤ 4 years ICD-9 diagnostic codes indicating neurological abnormalities Increased incidence of developmental or behavioral disorder, mental retardation, autism, and language or speech problems DiMaggio et al. [15]
Review of data from Young Netherlands Twin Register (1986-1995) No data No data Not specified 154 exposed vs. 648 individual controls 0–3 years 12 years Educational achievement (Cito) and Connor Teacher Rating Scale Educational scores lower in concordant twin pairs exposed to anesthesia compared with unexposed pairs. No difference in educational achievement comparing both twins in pairs discordant for exposure Bartels et al. [16]
Case-control study (1999-2005) ICD-9 procedural codes for surgery vs. absence of code No data Not specified 304 exposed vs. 10,146 controls 0–3 years ≤ 4 years ICD-9 diagnostic codes indicating neurological abnormalities Increased incidence of developmental or behavioral disorders following ≥ 2 exposures under 3 years of age DiMaggio et al. [17]
Birth cohort (1976-1982) Vaginal delivery with vs. without regional anesthesia No data Not specified 1,495 exposed vs. 3,189 controls At birth ≤ 19 years Review of school/educational records No association of regional anesthesia with learning abnormalities Flick et al. [18]
Birth cohort, matched design (1976-1982) General anesthesia before age 2 vs. no anesthetic exposure Halothane, N2O, not quantified 133 ± 239 min (median: 75 min 350 exposed vs. 700 controls 0–2 years ≤ 19 years Review of school/educational records Exposure to multiple, but not single anesthetics increased the risk of developing a learning disability Flick et al. [19]
Prospective treatment cohort (2003-2006) Sedation, anesthesia, analgesia for congenital heart surgery vs. population norms Doses for ketamine, benzodiazepines, chloral hydrate, opioids, inhalation agents quantified Not specified 95 ≤ 6 weeks 18–24 months BSID-II and BSID-III No evidence for an association between sedation/analgesia variables and mental, motor, or vocabulary delay Garcia Guerra et al. [20]
Nationwide birth cohort (1986-1990) Inguinal hernia repair vs. randomly selected 5% population sample No data Not specified 2,689 exposed vs. 14,575 controls Infancy 15–16 years Academic performance during 9th grade exam and teacher rating No significant differences in test scores; increased non-attainment was attenuated when adjusting for congenital malformations Hansen et al. [21]
Birth cohort (1989-1992) Anesthetic exposure vs. no exposure No data Not specified 321 exposed vs. 2,287 controls 0–3 years ≤ 10 years CELF, CPM Increased risk for language and cognitive disability even after single exposure Ing et al. [22]
Cohort study Inguinal hernia repair, orchidopexy, pyloro-myotomy, and/or circumcision vs. population norms No data Range 1-12 hours 58 Infancy 7–10 years Academic performance (Iowa Tests of Basic Skills and Educational Development) Patients without potential risk factors for preexisting CNS abnormalities did not score lower than the population norm, but scored below the 5th percentile more than the Iowa population Block et al. [23]
Longitudinal, observational cohort (2001-2004) Infant surgeries, including inguinal hernia repair, PDA ligation, laparotomy vs. non-surgical patients in same cohort No data Not specified 30 exposed vs. 178 controls Neonatal period in premature infants (< 33 weeks) 2 years BSID-II No difference in PDI scores, but lower MDI scores, which were non-significant after adjustment for confounders Filan et al. [24]
Retrospective observational cohort study General anesthesia for inguinal hernia repair, circumcision, cystoscopy, pyloromyotomy vs. no exposure Sevoflurane 30–120 min (20% repeat exposures) 100 exposed vs. 106 controls < 1 year (4.4 ± 3.2 mo) 12 years Formal diagnosis of learning disability No difference in PSLE aggregate scores, but odds for diagnosis oflearning disability 4.5 times greater than for unexposed peers Bong et al. [25]
Nationwide birth cohort (1986-1990) Pyloromyotomy vs. randomly selected 5% population sample No data Not specified 779 exposed vs. 14,665 controls 0–3 months 15–16 years Academic performance during 9th grade exam and teacher rating No significant differences in test scores； increased non-attainment was attenuated when adjusting for VLBW infants Hansen et al. [26]
Prospective treatment cohort Strabismus surgery, cognitive performance before vs. after surgery sevoflurane, fentanyl (not further quantified) 67.3 ± 9.8 min 72 4–7 years 1 day before, 1 month, and 6 months after procedure WPPSI-III No decrease in postoperative cognitive ability when compared with preoperative performance Fan et al. [27]
Retrospective treatment cohort Neonates undergoing complex congenital heart surgery vs. population norms Doses for anesthetics and opioids quantified 4.4 MAC-hours 59 Infancy 12 months BSID-III Lower cognitive scores were associated with higher volatile anesthetic exposure Andropoulos et al. [28]
Prospective treatment cohort (2003-2006) Sedation/Anesthesia/Analgesia for congenital heart surgery vs. population norms Doses for ketamine, benzodiazepines, chloral hydrate, opioids, inhalation agents quantified 84 hours mean chloral hydrate exposure 91 ≤ 6 weeks 54 months WISC-III, VMI-V, Adaptive Behavior Assessment System-II Lower visual motor integration was associated with higher cumulative benzodiazepine dose and lower performance IQ with higher chloral hydrate dose Garcia Guerra et al. [29]
Australian birth cohort (1989-1992) Anesthetic exposure vs. no exposure No data Not specified 112 exposed vs. 669 controls 0–3 years ≤ 10 years CELF, CPM, ICD-9 code, academic achievement Increased risk for deficit as measured by directly administered neuropsychological test or ICD-9 diagnosis, but not by academic achievement scores Ing et al. [30]
Prospective test-retest study Before vs. following last anesthetic exposure for laser treatment Ketamine (8 mg/kgIM) 5 min for 1–3 exposures 49 exposed (20 once, 16 twice, and 13 three times) 10–12 months < 2 years BSID-II Decrease in mental development or psychomotor indices comparing baseline vs. following third exposure; no difference for 1–2 exposures; increase in S-100b plasma levels following all 3 exposures Yan et al. [31]
Nationwide, retrospective matched-birth cohort study (2001-2005) Anesthetic exposure vs. no exposure No data Not specified 3,293 exposed vs. 13,172 unexposed < 3 years > 3 years Diagnosis of Attention Deficit Hyperactivity Disorder (ICD- 9-CM code 314.01) No association with the diagnosis of ADHD Ko et al. [32]
Nationwide, retrospective birth cohort study (2001-2007) Anesthetic exposure vs. no exposure No data Not specified 5,197 exposed vs. 20,788 unexposed < 2 years 3–9 years Diagnosis of autism (ICD-9-CM 299.00) No association with the diagnosis of autistic disorder Ko et al. [33]
Matched cohort study Anesthetic exposure for mostly urological surgeries vs. no exposure Propofol, N2O, volatile anesthetics Not specified 28 vs. 28 < 1 year most around 10 months 6–11 years Recognition memory Tasks, WASl, CBCL Recollection memory significantly lower in both color and spatial tasks, no difference in familiarity, IQ or behavioral indices Stratmann et al. [34]
Cohort study matched for gender and age Anesthetic exposure for predominantly urological surgery vs. no exposure No data > 1 hour 65–317 min 160 ± 75 median 142 min 15 vs. 15 < 2 year 10–17 years fMRI activity (‘go/no-go’ attention task) No differences in performance accuracy and response time; activation differences detected in cerebellum, cingulate gyrus, and paracentral lobule. Taghon et al. [35]
Nationwide, retrospective birth cohort study (2004-2007) Cesarean section with general anesthesia (GA) vs. with regional anesthesia (RA) vs. vaginal birth No data Not specified 12,384 GA vs. 161,992 RA vs. 362,297 vaginal At birth 2–6 years Diagnosis of autism (ICD-9-CM code 299.0) Incidence of autism higher in neonates delivered by C-section with GA than in neonates delivered vaginally or with regional anesthesia Chien et al. [36]
Cohort study matched for gender, age, handedness, and socioeconomic status Anesthetic exposure for predominantly ENT surgery vs. no exposure Halothane, N2O, sevoflurane 37 ± 37 min (range 5–170 min) 53 exposed vs. 53 controls < 4 years 5–18 years WISC/WAIS, OWLS, MRI Lower scores in listening comprehension and performance IQ, which was associated with lower gray matter density in the occipital cortex and cerebellum Backeljauw et al. [37]
Randomized controlled trial Inguinal hernia repair with general anesthesia (GA) vs. with regional anesthesia (RA) Sevoflurane (2.6%/ hour) vs. caudal or spinal 54 min (41-70) 294 GA vs. 238 RA < 1 year 2.3 ± 1 months 2 years BSID-III No differences between groups Davidson et al. [38]
Sibling-matched cohort study Inguinal hernia repair with general anesthesia (GA) vs. unexposed sibling No data 84 ± 33 min median 80 min range 20–240 min 105 GA (10% female) vs. 105 unexposed (44% female) < 3 years 17 ± 11 months 8–15 years WASI, NEPSYII, WISC-IV, CBCL No statistically significant difference in full-scale IQ score between siblings with and without a single anesthesia exposure before age 3 years Sun et al. [39]
Nationwide birth cohort (1986-1990) Cleft lip and or palate repair vs. 5% sample of birth cohort No data Not specified Cleft lip (171), cleft lip and palate (222), or cleft palate (195)/controls (14,677) Median age 2.8 months for CL and CLP, 22.1 months for CP 15–16 years Danish standardized 9 th-grade exam Lower scores only in children with cleft palate repair, after adjustment for sex, birth weight, parental age, and parental level of education Clausen et al. [40]
Cohort study, matched for gender, gestational age at and year of birth, mothers age, and rurality of residence General anesthesia before age 4 vs. no anesthetic exposure, excluding children with known behavioral, learning, and developmental disability No data Not specified 28,366 exposed/55,910 controls (36% female) 0–6 years 5–6 years EDI Reduced physical health and wellbeing, social knowledge and competence, and emotional health and maturity scores in older age group (> 2 years during exposure) O’Leary et al. [41]
Cohort study, matched for gender, gestational age at birth, socioeconomic status General anesthesia in the neonatal period for correction of gastrointestinal malformations No data 145 min (95% CI 115–175 min) 40 exposed (63% male)/40 controls (63% male) < 28 days 2 years BSID-II No difference in PDI, but significantly lower verbal scale of MDI Doberschuetz et al. [42]
Matched cohort study, matched for gestational age General anesthesia before age 4 vs. no anesthetic exposure, excluding children with developmental disabilities (DD) diagnosed prior to 5 years No data Not specified 3,850 single, 620 multiple, 13,586 no exposures 0–4 years 5 years EDI Deficits in communication/ general knowledge and language/cognition parts of EDI following exposure between 2-4, but not 0-2 years Graham et al. [43]
Nationwide birth cohort (1973-1993) Single vs. multiple vs. no anesthetic exposure before age 4 No data Not specified 33,514 single, 3,640 multiple, 159,619 matched 0–4 years 16/18 years School grades (age 16) and IQ test during military conscription test (age 18) Small decrease in school grades by 0.12–0.7% or IQ by 0.15–1.8%, strongest effect for exposures between 37–48 or 25–36 months of age, respectively. No differences between number of exposures Glatz et al. [44]
Birth cohort (1994-2007), propensity-matched Single vs. multiple vs. no anesthetic exposure before age 3 Sevoflurane, N2O, isoflurane, not quantified None vs. 61 ± 51 vs. 295 ± 354 min (median: 45 vs. 187 min exposures 380 single and 206 multiply exposed vs. 411 controls 0–3 years 8–12 or 15–20 years WASI, CTOPP, Fine Motor Composite, Single or multiple exposures did not diminish subsequent IQ, processing speed and fine motor skills were decreased in multiply, but not singly exposed Warner et al. [45]

BSID-II or BSID-III: Bayley Scales of Infant Development, 2nd or 3rd Edition, CBCL: Achenbach Child Behavior Checklist Parental Assessment, CELF: Clinical Evaluation of Language Fundamentals, CP: Cerebral Palsy, CPM: Raven’s Colored Progressive Matrices, CTOPP: Comprehensive Test of Phonological Processing, EDI: Early Development instrument, ELBW: Extremely Low Birth Weight (< 1,000 g), FSIQ: Full Scale Intelligence Quotient, ICD: International Statistical Classification of Diseases, IM: intramuscular, IQ: Intelligence Quotient, MDI: Bayley Mental Development Index, MPC: Mental Composite Score of the Kaufman Assessment Battery for Children, NEPSY-II: Developmental Neuropsychological Assessment, 2nd Edition, PCA: Postconceptual Age, PDA: Patent Ductus Arteriosus, PDI: Bayley Psychomotor Developmental Index, VMI: Developmental Test of Visual Motor Integration, VLBW: Very Low Birth Weight (≤ 1,500 g), WAIS: Wechsler Adult Intelligence Scales, WASI: Wechsler Abbreviated Scales of Intelligence, WISC-III: Wechsler Intelligence Scale for Children, 3rd Edition, WISC-IV: Wechsler Intelligence Scale for Children, 4th Edition, WPPSI: Wechsler Preschool and Primary Scales of Intelligence.

TOOLS
Similar articles